19 November 2017
News and Views
Links and Services
A meta-analysis in the most recent issue of Alimentary Pharmacology of Therapeutics evaluates anti-viral therapy outcomes in HCV genotype 2 and 3 infected patients.
Anti-viral therapy seems more successful in Hepatitis C virus genotype 2 than genotype 3-infected
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors